I thank AfME for keeping patients updated as this situation moves forward.
My view, that I will be expressing to AfME who I have been in communications with, is that some individual patient participants may well feel they did not give consent for such de-identified data to be released, and I understand they are upset in principle that the consent form they signed did not mention this. But actually by taking part in a trial under data protection laws as they are, that consent was never required for de-identified data to be released. It is normal for de-identified data to be released and it was always subject to potential release under FOI law. Without that it is difficult for trials to have much value. Release is safe because patients cannot be identified.
Indeed, the PACE authors have already released some of the de-identified data. Both in their published papers and to an outside research team who are currently writing a paper for publication. So the PACE authors themselves have already broken their agreement if we look at their agreement the way the PACE authors say they want it looked at. Have AfME made the patient partiiciapants aware that some IPD have already been released without consent being requested?
I sympathise with patient participants who may not feel they can trust the PACE authors anymore, and that may be part of the reason why they just want to say no, please keep things as they are. And if they have read any of the statements from QMUL it is likely they are under the false impression that the data release would lead to them being identified, but this is not true; the information commissioner has already rejected QMUL's asserions on this matter - still I could understand if a patient participant felt uncertain given the scaremongering QMUL have put about. And who knows what QMUL have said to them in private!
But as it is not true that patients can be identified from the de-identified data we're talking about here, that is why the reality is that patient consent is not required for the release of de-identified data (we're talking about things like numbers of steps taken, not names or postcodes).
Despite a small number of patient participants rightly feeling this process has been mismanaged by QMUL -- and I think QMUL should appologise to them for that mismanagement -- there is no actual risk to these individual patient participants who have raised these concerns and as there are tens of thousands of patients who want the data to be released, and so release would clearly still be in the interest of the vast majority of patients, AfME should clearly support that.
If you are a patient yourself (or even a patient participant from the trial), a carer, or advocate, and you want the data released, then I encourage you to contact AfME if you have not already done so..